SC
CVS icon

Scholtz & Company’s CVS Health CVS Stock Holding History

Scholtz & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,168
Closed -$336K – 70
2020
Q2 		$336K Buy
5,168
+75
+1% +$4.72K 0.17% 51
2020
Q1 		$302K Buy
+5,093
New +$340K 0.23% 45
2016
Q4 		– Sell
-44,126
Closed -$3.93M – 41
2016
Q3 		$3.93M Buy
44,126
+221
+0.5% +$20.9K 4.06% 11
2016
Q2 		$4.2M Sell
43,905
-285
-0.6% -$28.4K 4.32% 2
2016
Q1 		$4.58M Buy
44,190
+525
+1% +$51K 4.58% 4
2015
Q4 		$4.27M Buy
+43,665
New +$4.28M 4.49% 8

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Scholtz & Company's CVS Position: Q3 2020 in Review

Scholtz & Company sold out of CVS Health (CVS) in Q3 2020, closing a stake of 5,168 shares — an estimated $336K sold.

Scholtz & Company first reported a position in CVS in Q4 2015 and held it in 6 quarters. The position peaked at $4.58M in Q1 2016. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Scholtz & Company reported no remaining CVS Health position as of Q3 2020 after selling out during the quarter.
  • Scholtz & Company sold 5,168 CVS Health shares in Q3 2020, an estimated $336K.
  • Scholtz & Company first reported a position in CVS Health in Q4 2015 and held it in 6 quarters.
  • Scholtz & Company's CVS Health position peaked at $4.58M in Q1 2016.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Scholtz & Company's 13F filing for Q3 2020, filed 16 Nov 2020.